Skip to main content
OpenTrials
Completed

NCT Number: NCT06085430

Kubota Glass Parameter Refinement Study

Length of the eye will be measured in subjects exposed to various stimulus characteristics using an electronic spectacle which presents illuminated targets to the eye. The results will be analyzed to determine which stimulus characteristics may be most beneficial for use in the device.

Completed

Looking for future studies?

Notify Me

Key information

Age range

8 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

InOptix Eyecare Center

Jacksonville, Florida, 32256, United States

About this study

Axial length measurements will be taken before and after two-hour monocular exposure to various stimulus characteristics using an electronic spectacle which presents illuminated defocus targets to the retina. Areas of investigation include the dioptric amount of defocus, the intensity of illumination, the spectrum of illumination, and the shape of the illumination target. The transient axial length results will be analyzed to determine which stimulus characteristics may be most beneficial for slowing myopic eye growth.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be of legal age or, if under legal age have written consent of their parent or guardian to participate.
  • Sign written Informed Consent (and the California Bill of Rights, if applicable).
  • Ages 8-24 (inclusive) and able to understand and assent to participation
  • Have need of optical correction for myopia, from -1.00 to -5.00 diopters (D).
  • Have a refractive astigmatism of less than -1.00 D.
  • Best Spectacle Corrected Visual Acuity (BSCVA) of 20/25 or better.
  • Be willing and able to follow instructions and attend the schedule of follow-up visits.

Exclusion criteria

  • Not able or willing to provide informed consent and assent
  • Eye injury or surgery within twelve weeks immediately prior to enrollment
  • Currently enrolled in an ophthalmic clinical trial
  • Pregnant or lactating or expect to become pregnant during the trial
  • Evidence of systemic or ocular abnormality, infection or disease
  • Any systemic disease including autoimmune disease, immunocompromising diseases, connective tissue disease, clinically significant atopic diseases, insulin dependent diabetes, use of medications including corticosteroids and antimetabolites that may affect the eye
  • Habitually uncorrected anisometropia ≥ 2.00
  • Subjects who have undergone corneal refractive surgery
  • Use of a treatment for myopia progression within the past 6 months, including atropine, specialized spectacle lenses, orthokeratology, specialized soft contact lenses

Treatment and study plan

Kubota Glass

Device

Kubota Glass employs white light producing micro-LEDs covered by masks which create a patterned target. The patterned images are defocused by micro-lenslets and projected to the retinal periphery by a central mirror. Parameters of interest to evaluate in this investigation include but are not limited to dioptric amount of defocus, brightness (cd/m2), spectrum of illumination, and shape of the target mask. In each scenario, right eyes will be exposed to the stimulus, whereas left eyes serve as controls. The order of exposures to the various stimuli will be randomized to participant and investigator.

Primary outcomes

  1. Axial length

    Time frame: 2 hours

    Change in axial length as measured by optical biometry after the use of Kubota Glass

Sponsors and collaborators

Lead sponsor

Kubota Vision Inc.

Industry

Registry information

Official study title

Effects of Various Stimulus Characteristics on Myopic Progression Using Kubota Glass

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 17, 2023
Registry last updated
Dec 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.